ImmPACT Bio

ImmPACT Bio is a clinical-stage biopharmaceutical company focused on developing a new generation of cell therapies for the treatment of cancer and autoimmune diseases. Their innovative approach utilizes logic-gate-based chimeric antigen receptor (CAR) T-cell platforms, licensed from UCLA, which are designed to overcome the limitations of current cell therapies. These platforms aim to prevent antigen escape, reduce toxicity, overcome immunosuppression in the tumor microenvironment, and improve cell persistence, leading to more effective and safer treatments for patients.

ImmPACT Bio is actively advancing multiple clinical programs across various therapeutic areas. Their lead program, IMPT-514, is a CD19/CD20 bispecific CAR T-cell therapy currently under investigation for the treatment of multiple sclerosis. They also have programs for treating various types of B-cell lymphoma and are exploring the potential of their CAR T-cell therapies for the treatment of solid tumors and other autoimmune diseases. ImmPACT Bio is committed to pushing the boundaries of cell therapy and delivering transformative treatments to patients in need.

ImmPACT Bio offers flexible work arrangements for its US employees, including generous paid time off, personal days, vacation days, and an annual company shutdown. They also provide weekly meals and healthy snacks for on-site employees, as well as access to two complimentary on-site gyms and wellness classes. These benefits demonstrate ImmPACT Bio's commitment to employee well-being and work-life balance.

ImmPACT Bio offers a comprehensive benefits package that includes competitive base pay with bonuses, low-cost medical plans, no-cost dental and vision insurance starting on the first day, equity for all employees, a 401K with employer match, generous paid time off, personal days, and vacation days, an annual shutdown, weekly meals and healthy snacks for on-site employees, two complimentary on-site gyms and wellness classes, free events, parties, bands, hikes and games, and community service opportunities.

ImmPACT Bio is a clinical-stage biopharmaceutical company dedicated to developing a new generation of cell therapies with the potential to cure cancer, autoimmune diseases, and other serious conditions. They strive to push the limits of immune cell therapies by creating innovative CAR T cell platforms designed to prevent antigen escape, reduce toxicity, overcome immunosuppression in the tumor microenvironment, and improve cell persistence. Their mission is to empower patients to live to the fullest by delivering on the promise of these groundbreaking therapies.

ImmPACT Bio emphasizes a culture of collaboration, innovation, and patient-centricity. They foster a supportive and diverse environment where employees with diverse backgrounds can contribute their expertise and ideas. The company values integrity, ingenuity, and passion, encouraging employees to push boundaries and deliver on the promise of immune cell therapies to empower patients. This is further reflected in their commitment to providing competitive benefits, including healthcare, equity, and wellness programs, creating a strong sense of community and a shared goal of making a positive impact on patients' lives.

ImmPACT Bio is committed to fostering a diverse, equitable, and inclusive workplace where all individuals feel valued, respected, and empowered to contribute their unique talents and perspectives. The company embraces diverse backgrounds, cultures, and experiences, believing that a variety of perspectives leads to innovation and better outcomes for patients. ImmPACT Bio is an Equal Opportunity Employer that strives to create a welcoming and supportive environment for all employees, promoting a culture of respect, collaboration, and inclusivity.